Regeneron Pharmaceuticals Piotroski F Score

REGN -- USA Stock  

USD 286.15  1.09  0.38%

This module uses fundamental data of Regeneron Pharmaceuticals to approximate its Piotroski F score. Regeneron Pharmaceuticals F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Regeneron Pharmaceuticals. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Regeneron Pharmaceuticals financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Additionally take a look at Regeneron Pharmaceuticals Altman Z Score, Regeneron Pharmaceuticals Correlation, Regeneron Pharmaceuticals Valuation as well as analyze Regeneron Pharmaceuticals Alpha and Beta and Regeneron Pharmaceuticals Hype Analysis.
Symbol
Analyze Piotroski F Score
3
Piotroski F Score -- Frail
1
Current Return On Assets
Positive
2
Change in Return on Assets
Decreased
3
Cash Flow Return on Assets
Positive
4
Current Quality of Earnings (accrual)
Decreasing
5
Asset Turnover Growth
Decrease
6
Current Ratio Change
Decrease
7
Long Term Debt Over Assets Change
Higher Leverage
8
Change In Outstending Shares
Increase
9
Change in Gross Margin
Increase
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares108 M107.9 M
Slightly Up
Increasing
Slightly volatile
Weighted Average Shares Diluted104.9 M114.8 M
Significantly Down
Increasing
Slightly volatile
Net Cash Flow from Operations1.1 B2.2 B
Way Down
Increasing
Slightly volatile
Total Assets5.6 B11.7 B
Way Down
Increasing
Slightly volatile
Total Liabilities2.2 B3 B
Way Down
Increasing
Slightly volatile
Current Assets2.9 B6.4 B
Way Down
Increasing
Slightly volatile
Current Liabilities811.2 M1.4 B
Way Down
Increasing
Slightly volatile
Total Debt711.3 M431 M
Way Up
Increasing
Slightly volatile
Return on Average Assets0.115723.8492
Way Down
Increasing
Slightly volatile
Gross Margin10493.5313
Moderately Up
Decreasing
Stable
Asset Turnover0.63580.6548
Fairly Down
Increasing
Slightly volatile

Regeneron Pharmaceuticals F Score Driver Matrix

Current Sentiment - REGN

Regeneron Pharmaceuticals Investor Sentiment

Majority of Macroaxis users are at this time bullish on Regeneron Pharmaceuticals. What is your perspective on investing in Regeneron Pharmaceuticals? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

About Regeneron Pharmaceuticals F Score

What is Regeneron Pharmaceuticals Piotroski F-Score?

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book

Regeneron Pharmaceuticals Book Changes

Book Value per Share
Price to Book Value
Tangible Assets Book Value per Share


 
Search macroaxis.com